Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Post Reproductive Health|January 18, 2018
Menopause and cardiovascular diseaseLouise Newson
Menopause (New York, N.Y.)|February 11, 2025
Patient experience of menopause care after breast cancer in the UK: a cross-sectional studySarah Glynne, Daniel Reisel, Aini Kamal, et al.
Cancer Journal (Sudbury, Mass.)|May 20, 2022
Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer DevelopmentAbbie J Laing, Louise Newson, James A Simon
Translational Andrology and Urology|April 13, 2026
Incidence of venous thromboembolism in women receiving transdermal oestradiol/testosterone with micronised progesterone in accordance with NICE guidelinesAmy Neville, Dan Reisel, John Benton, et al.
Menopause (New York, N.Y.)|February 25, 2025
Breast cancer patients' experience of menopause care in the UK: thematic analysis of free-text commentsSarah Glynne, Kathy Seymour, Daniel Reisel, et al.
Advances in Therapy|November 21, 2025
Menopause and Mental HealthClair Crockett, Georgie Lichtveld, Rebecca Macdonald, et al.
Archives of Women'S Mental Health|September 16, 2024
Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot studySarah Glynne, Aini Kamal, Ahmed M Kamel, et al.
Frontiers in Global Women'S Health|November 24, 2021
Sensitive to Infection but Strong in Defense-Female Sex and the Power of Oestradiol in the COVID-19 PandemicLouise Newson, Isaac Manyonda, Rebecca Lewis, et al.
Maturitas|July 3, 2024
What are the health needs of women with female genital mutilation going through menopause?Aini Kamal, Sarian Kamara, Rajvinder Khasriya, et al.
Menopause (New York, N.Y.)|April 6, 2026
Use of transdermal testosterone to treat menopausal symptoms in women with a history of breast cancer: a small, retrospective, open-label studySarah Glynne, Aini Kamal, Amy Neville, et al.
Pageof 3